Literature DB >> 2991519

Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application.

H W Hamilton, D F Ortwine, D F Worth, E W Badger, J A Bristol, R F Bruns, S J Haleen, R P Steffen.   

Abstract

A set of 56 8-phenylxanthines, previously tested for adenosine antagonism (adenosine A1 receptor affinity), was analyzed by quantitative structure-activity relationship (QSAR) techniques. The resulting QSAR revealed that (1) the most potent receptor binders had already been made in this series and thus suggested the termination of synthesis of compounds with additional phenyl substituents to increase potency and (2) potency was much more strongly affected by changes in ortho than para phenyl substitution. On the basis of this study, an additional 20 compounds were synthesized that contained primarily para substituents designed to increase aqueous solubility. High potency was maintained among the resulting sulfonamide derivatives (as predicted by the QSAR), and aqueous solubility was dramatically increased. Furthermore, in vitro antagonism of an adenosine receptor mediated physiological effect was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991519     DOI: 10.1021/jm00146a016

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.

Authors:  K N Klotz; H Vogt; H Tawfik-Schlieper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

2.  Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node.

Authors:  D Dennis; K Jacobson; L Belardinelli
Journal:  Am J Physiol       Date:  1992-03

3.  [3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.

Authors:  K A Jacobson; D Ukena; K L Kirk; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines.

Authors:  Giuseppe Faudone; Whitney Kilu; Xiaomin Ni; Apirat Chaikuad; Sridhar Sreeramulu; Pascal Heitel; Harald Schwalbe; Stefan Knapp; Manfred Schubert-Zsilavecz; Jan Heering; Daniel Merk
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-23

5.  The distribution of A1 adenosine receptor and 5'-nucleotidase in pig brain cortex subcellular fractions.

Authors:  V Casadó; C Lluis; E Canela; R Franco; J Mallol
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

6.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

7.  PD 115,199: an antagonist ligand for adenosine A2 receptors.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; S J Hays
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

8.  8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors.

Authors:  K A Jacobson; R de la Cruz; R Schulick; L Kiriasis; W Padgett; W Pfleiderer; K L Kirk; J L Neumeyer; J W Daly
Journal:  Biochem Pharmacol       Date:  1988-10-01       Impact factor: 5.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.